Clinical Trial

Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2026 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled pretest-posttest experimental study aims to evaluate the effect of virtual reality (VR) on pain and anxiety levels experienced during Pap smear sampling. Although cervical cancer is largely preventable through regular screening, many women avoid Pap smear testing due to anxiety, fear of pain, and discomfort during gynecological examinations. Innovative, non-invasive interventions are needed to improve women's screening experiences and participation rates. The study will be conducted in a gynecology outpatient clinic with 60 women aged 18-65 years who meet the inclusion criteria and provide informed consent. Participants will be randomly assigned to either the intervention group (VR headset during the procedure) or the control group (standard care). Women in the intervention group will watch a 360° relaxing nature video during the Pap smear procedure. Data will be collected using a Personal Information Form, the State Anxiety Inventory, and the Visual Analog Scale (VAS). The findings may support integrating VR into clinical practice to enhance patient comfort during screening procedures.
Trial Details
NCT Number NCT07462039
Lead Sponsor Eastern Mediterranean University
Conditions Nurse's Role, Pain Management, Cervical Cancer Screening, Anxiety
Enrollment 60 participants
Start Date 2026-03-10
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-05-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-10